Literature DB >> 17420272

LAT and NTAL mediate immunoglobulin E-induced sustained extracellular signal-regulated kinase activation critical for mast cell survival.

Sho Yamasaki1, Eri Ishikawa, Machie Sakuma, Osami Kanagawa, Alec M Cheng, Bernard Malissen, Takashi Saito.   

Abstract

Immunoglobulin E (IgE) induces mast cell survival in the absence of antigen (Ag) through the high-affinity IgE receptor, Fcepsilon receptor I (FcepsilonRI). Although we have shown that protein tyrosine kinase Syk and sustained extracellular signal-regulated kinase (Erk) activation are required for IgE-induced mast cell survival, how Syk couples with sustained Erk activation is still unclear. Here, we report that the transmembrane adaptors LAT and NTAL are phosphorylated slowly upon IgE stimulation and that sustained but not transient Erk activation induced by IgE was inhibited in LAT(-/-) NTAL(-/-) bone marrow-derived mast cells (BMMCs). IgE-induced survival requires Ras activation, and both were impaired in LAT(-/-) NTAL(-/-) BMMCs. Sos was preferentially required for FcepsilonRI signals by IgE rather than IgE plus Ag. Survival impaired in LAT(-/-) NTAL(-/-) BMMCs was restored to levels comparable to those of the wild type by membrane-targeted Sos, which bypasses the Grb2-mediated membrane recruitment of Sos. The IgE-induced survival of BMMCs lacking Gads, an adaptor critical for the formation of the LAT-SLP-76-phospholipase Cgamma (PLCgamma) complex, was observed to be normal. IgE stimulation induced the membrane retention of Grb2-green fluorescent protein fusion proteins in wild-type but not LAT(-/-) NTAL(-/-) BMMCs. These results suggest that LAT and NTAL contribute to the maintenance of Erk activation and survival through the membrane retention of the Ras-activating complex Grb2-Sos and, further, that the LAT-Gads-SLP-76-PLCgamma and LAT/NTAL-Grb2-Sos pathways are differentially required for degranulation and survival, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420272      PMCID: PMC1900065          DOI: 10.1128/MCB.02109-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

Review 1.  Selecting and maintaining a diverse T-cell repertoire.

Authors:  A W Goldrath; M J Bevan
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 2.  NTAL/LAB and LAT: a balancing act in mast-cell activation and function.

Authors:  Juan Rivera
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

3.  Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases.

Authors:  Jiro Kitaura; Koji Eto; Tatsuya Kinoshita; Yuko Kawakami; Michael Leitges; Clifford A Lowell; Toshiaki Kawakami
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 4.  New experimental approaches in retrovirus-mediated expression screening.

Authors:  T Kitamura
Journal:  Int J Hematol       Date:  1998-06       Impact factor: 2.490

5.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation.

Authors:  Satoru Sasagawa; Yu-ichi Ozaki; Kazuhiro Fujita; Shinya Kuroda
Journal:  Nat Cell Biol       Date:  2005-03-27       Impact factor: 28.824

6.  A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.

Authors:  Jeroen P Roose; Marianne Mollenauer; Vikas A Gupta; James Stone; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Regulation of mast cell activation through FcepsilonRI.

Authors:  Sho Yamasaki; Takashi Saito
Journal:  Chem Immunol Allergy       Date:  2005

8.  B-Raf contributes to sustained extracellular signal-regulated kinase activation associated with interleukin-2 production stimulated through the T cell receptor.

Authors:  Hirotake Tsukamoto; Atsushi Irie; Yasuharu Nishimura
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

9.  Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen.

Authors:  Masayuki Kohno; Sho Yamasaki; Victor L J Tybulewicz; Takashi Saito
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

10.  Fc{epsilon}RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane.

Authors:  Keigo Nishida; Satoru Yamasaki; Yukitaka Ito; Koki Kabu; Kotaro Hattori; Tohru Tezuka; Hirofumi Nishizumi; Daisuke Kitamura; Ryo Goitsuka; Raif S Geha; Tadashi Yamamoto; Takeshi Yagi; Toshio Hirano
Journal:  J Cell Biol       Date:  2005-07-04       Impact factor: 10.539

View more
  6 in total

Review 1.  LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?

Authors:  Selinda J Orr; Daniel W McVicar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

Review 2.  A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity.

Authors:  Deirdre M Fuller; Minghua Zhu; Chih-Wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 3.  Regulation of lymphocyte development and activation by the LAT family of adapter proteins.

Authors:  Deirdre M Fuller; Weiguo Zhang
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

4.  IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species.

Authors:  Laura M Sly; Janet Kalesnikoff; Vivian Lam; Dana Wong; Christine Song; Stephanie Omeis; Karen Chan; Corinna W K Lee; Reuben P Siraganian; Juan Rivera; Gerald Krystal
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Cytokinergic IgE Action in Mast Cell Activation.

Authors:  Heather J Bax; Anthony H Keeble; Hannah J Gould
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

6.  Transmembrane adaptor proteins in the high-affinity IgE receptor signaling.

Authors:  Petr Draber; Ivana Halova; Francesca Levi-Schaffer; Lubica Draberova
Journal:  Front Immunol       Date:  2012-01-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.